Whole Genome Sequencing of Lumpy Skin Disease Virus from 2021–2023 in Eastern Eurasia Reveals No More Recombination Signals in the Circulating Pool of Strains

Alexander Sprygin, Alena Krotova, Jun Ma, Olga Byadovskaya, Владимир Кирпиченко, Jinchao Chen, Tserenchimed Sainnokhoi, I. A. ChvalaViruses 2025 · DOI

TL;DR

This study analyzed the whole genomes of Lumpy Skin Disease Virus (LSDV) from Eastern Eurasia (Russia and Mongolia) collected between 2021-2023. The findings indicate that the previously observed recombinant strains have disappeared, and a specific lineage, "cluster 2.5," has become the dominant circulating strain in the region, exhibiting a more stable, monophyletic evolutionary pattern. This shift is crucial for understanding LSDV spread and developing effective control strategies.

What Problem Does This Paper Address?

Lumpy Skin Disease (LSD) is a significant threat to the global cattle industry, causing substantial economic losses and trade restrictions. In recent years, LSDV has rapidly spread across Eurasia, with a notable emergence of "recombinant" strains, particularly in Russia and Southeast Asia. These recombinant strains, often linked to contaminated vaccines, were characterized by mosaic genetic structures and a unique evolutionary trajectory. Understanding the current molecular epidemiology of LSDV, specifically whether these recombinant strains persist or if a new dominant lineage has emerged, is critical for effective disease surveillance, control, and vaccine development. This paper aims to address this by investigating the genetic makeup of LSDV circulating in Eastern Eurasia from 2021-2023 to determine the current evolutionary dynamics and the presence of recombination signals.

Methods

The researchers employed whole-genome sequencing (WGS) of LSDV isolates directly from clinical samples (skin nodules) collected from active outbreaks in Russia and Mongolia between 2020 and 2023. This direct-from-sample approach bypasses the need for cell culture, which can sometimes introduce biases.

Key methodological steps included:

  • DNA Extraction and Sequencing: DNA was extracted from tissue samples using Trizol. Fragments were prepared for sequencing using a Covaris focused-ultrasonicator and processed with the MGIEasy Universal DNA Library Prep Set. Sequencing was performed on the DNBSEQ-G50 platform using a pair-end 150 sequencing protocol, generating high-throughput data.
  • Bioinformatics Analysis: Raw sequencing data underwent quality control (FASTQC) and filtering (PRINSEQ). Cleaned reads were mapped against a reference genome (China/GD01/2020 strain, a cluster 2.5 isolate) using bowtie2. Consensus sequences were generated with a high depth threshold (at least 90% coverage and a minimum depth of 400) to ensure accuracy.
  • Phylogenetic Analysis: A total of 97 whole-genome sequences, including the 11 newly generated ones and existing sequences from GenBank, were aligned using MAFFT and trimmed with trimAl. The best-fitting DNA substitution models were identified using ModelTest-NG. Maximum Likelihood (ML) phylogenetic trees were constructed using RAxML with 1000 bootstrap replicates. Single nucleotide polymorphism (SNP) differences were analyzed using the SNP-sites package.

Datasets

The study utilized two main sources of data:

  1. Newly Generated Sequences: Whole genome sequences from 11 LSDV isolates collected from active outbreaks in Russia (Tuva, Buryatiya, Transbaykal, Amur, Khakassia, Udmurtiya regions) and Mongolia between 2021 and 2023. These sequences have been deposited in GenBank under accession numbers PQ727625-PQ727635.
  2. Publicly Available Sequences: 97 whole-genome sequences of LSDV, including virulent isolates and vaccine strains, retrieved from GenBank. These were used for comparative phylogenetic analysis.

No new benchmark datasets were introduced; the study relied on existing publicly available genomic data for comparison.

Key Insights and Ideas

  • Disappearance of Recombinant Strains: A major finding is the apparent absence of the mosaic, recombinant LSDV strains that were prevalent in Russia and Kazakhstan between 2017-2019. This suggests a potential shift in the circulating viral population.
  • Dominance of Cluster 2.5: The study strongly supports the idea that "cluster 2.5" has become the dominant lineage in Eastern Eurasia, and likely Southeast Asia, displacing previous strains. This lineage appears to be evolving in a more stable, monophyletic manner.
  • Implications for Vaccine Efficacy: The dominance of a specific lineage like cluster 2.5 has direct implications for vaccine strategies. Understanding the genetic characteristics of this dominant strain is crucial for ensuring that current vaccines remain effective.
  • Potential for Human-Assisted Introduction: The presence of certain lineages, particularly those not fitting neatly into established clusters, raises questions about their origin, suggesting potential human-assisted introduction rather than natural evolutionary spread.

Key Results

  • Phylogenetic Placement: All 11 newly sequenced LSDV isolates from Russia and Mongolia (2021-2023) clustered within "cluster 2.5."
  • High Genetic Identity: The analyzed sequences within cluster 2.5 showed very high genetic identity, with the overall identity within the cluster varying from 99.6% to 100%. The identity among the newly sequenced isolates was even higher, ranging from 0 to 13 SNPs.
  • Absence of Recombination Signals: The WGS data and phylogenetic analysis did not reveal any new recombinant strains or mosaic variants in the circulating LSDV pool from 2021-2023.
  • Monophyletic Evolution: Cluster 2.5 strains exhibited patterns of monophyletic evolution, indicating a more consistent and less fragmented genetic history compared to the previously observed recombinant strains.
  • Geographic Spread: The study confirms the ongoing spread of cluster 2.5 strains across Southeast Asian countries, including China, Thailand, Vietnam, and South Korea.

Limitations and Future Work

  • Geographic Scope: While the study focused on Eastern Eurasia (Russia and Mongolia), the findings on cluster 2.5 dominance are extrapolated to Southeast Asia based on existing literature. Further WGS data from a broader range of Asian countries would strengthen these conclusions.
  • Origin of Non-Conforming Lineages: The paper highlights the presence of certain lineages that don't fit neatly into established clusters, suggesting human-assisted introduction. Further research is needed to elucidate the exact mechanisms and pathways of these introductions.
  • Vaccine Efficacy Validation: While cluster 2.5 is dominant, the paper notes the need for continued validation of vaccine efficacy against this specific lineage, especially given the history of recombinant strains and potential for altered virulence.
  • Surveillance Strategies: The authors emphasize the need for ongoing surveillance, particularly focusing on lineage determination and tracking virus evolution, to guide informed vaccine decisions and control measures. The development of molecular tools for differentiating current circulating clusters is highlighted as a key future direction.

Summary updated

Abstract

Having spanned thousands of kilometers from Africa through Europe, the Middle East, Central Asia through to the south eastern part of Eurasia in the recent decade, lumpy skin disease virus has now become entrenched in China, Thailand, Vietnam, and South Korea. In light of discovered findings on recombination, cluster 2.5 lineage strains are now dominant and continue to spread throughout Southeast Asia. To gain a better picture of the phylogenetic landscape in the field, whole genome sequencing of 11 LSDV isolates from Russia and Mongolia collected from 2021 to 2023 has been attempted to see the dynamics of recombination signals, as was shown for LSDV circulating in 2017-2019 in Russia and Kazakhstan. Deep sequencing performed direct from skin nodules along with data retrieved from Genbank provides the most recent update on molecular epidemiology of LSDV and demonstrates that no more mosaic variant of LSDV has been observed, and cluster 2.5 lineage is now the dominant lineage currently on the rise in the region with its own patterns of monophyletic evolution. These discoveries may help future investigations aimed at epidemiological surveillance and virus tracking in the context of currently identified lineages worldwide.
BibTeX
@inproceedings{sprygin2025whole,
  author = {Alexander Sprygin and Alena Krotova and Jun Ma and Olga Byadovskaya and Владимир Кирпиченко and Jinchao Chen and Tserenchimed Sainnokhoi and I. A. Chvala},
  title = {{Whole Genome Sequencing of Lumpy Skin Disease Virus from 2021–2023 in Eastern Eurasia Reveals No More Recombination Signals in the Circulating Pool of Strains}},
  booktitle = {Viruses},
  year = {2025},
  doi = {10.3390/v17040468},
}
Figure